Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (151-160 of 672) with videos related to

Pageof 68
Sort By:
The Journal of Rheumatology|April 17, 2014
Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatmentIhsane Hmamouchi, Christian Roux, Simon Paternotte, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Flare in axial spondyloarthritis: investigation of meaningful changes in symptomatic outcome measuresMaxime Dougados, Emily Wood, Laure Gossec, et al.
The Journal of Rheumatology|May 17, 2013
Anterior chest wall pain in recent inflammatory back pain suggestive of spondyloarthritis. data from the DESIR cohortDaniel Wendling, Clément Prati, Christophe Demattei, et al.
The Journal of Rheumatology|April 17, 2018
The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA StudyMarion Couderc, Bruno Pereira, Anna Molto, et al.
The Journal of Rheumatology|April 17, 2016
Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic ErosionsIsabel Castrejón, Maxime Dougados, Bernard Combe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Brief Report: Nonsteroidal Antiinflammatory Drug-Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR CohortAnna Moltó, Benjamin Granger, Daniel Wendling, et al.
Joint Bone Spine|May 18, 2010
Gait analysis as a quantifiable outcome measure in hip or knee osteoarthritis: a systematic reviewPaul Ornetti, Jean-Francis Maillefert, Davy Laroche, et al.
RMD Open|July 26, 2024
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohortClementina López-Medina, Anna Molto, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases|December 25, 2025
Evaluation of the placebo and treatment effect overtime in randomised clinical trials evaluating the efficacy of biologics in axial spondyloarthritis: systematic review and meta-analysisLéa Perrot, Anna Molto, Caroline Paris, et al.
Arthritis and Rheumatism|April 9, 2005
Impact of ultrasound imaging on local corticosteroid injections of symptomatic ankle, hind-, and mid-foot in chronic inflammatory diseasesMaria-Antonietta d'Agostino, Xavier Ayral, Gabriel Baron, et al.
Pageof 68

Showing results (151-160 of 672) with videos related to

Sort By:
Pageof 68
The Journal of Rheumatology|April 17, 2014
Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatmentIhsane Hmamouchi, Christian Roux, Simon Paternotte, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Flare in axial spondyloarthritis: investigation of meaningful changes in symptomatic outcome measuresMaxime Dougados, Emily Wood, Laure Gossec, et al.
The Journal of Rheumatology|May 17, 2013
Anterior chest wall pain in recent inflammatory back pain suggestive of spondyloarthritis. data from the DESIR cohortDaniel Wendling, Clément Prati, Christophe Demattei, et al.
The Journal of Rheumatology|April 17, 2018
The Prevalence of Renal Impairment in Patients with Spondyloarthritis: Results from the International ASAS-COMOSPA StudyMarion Couderc, Bruno Pereira, Anna Molto, et al.
The Journal of Rheumatology|April 17, 2016
Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic ErosionsIsabel Castrejón, Maxime Dougados, Bernard Combe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Brief Report: Nonsteroidal Antiinflammatory Drug-Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR CohortAnna Moltó, Benjamin Granger, Daniel Wendling, et al.
Joint Bone Spine|May 18, 2010
Gait analysis as a quantifiable outcome measure in hip or knee osteoarthritis: a systematic reviewPaul Ornetti, Jean-Francis Maillefert, Davy Laroche, et al.
RMD Open|July 26, 2024
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohortClementina López-Medina, Anna Molto, Alexandre Sepriano, et al.
Annals of the Rheumatic Diseases|December 25, 2025
Evaluation of the placebo and treatment effect overtime in randomised clinical trials evaluating the efficacy of biologics in axial spondyloarthritis: systematic review and meta-analysisLéa Perrot, Anna Molto, Caroline Paris, et al.
Arthritis and Rheumatism|April 9, 2005
Impact of ultrasound imaging on local corticosteroid injections of symptomatic ankle, hind-, and mid-foot in chronic inflammatory diseasesMaria-Antonietta d'Agostino, Xavier Ayral, Gabriel Baron, et al.
Pageof 68